Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors
Cetuximab and panitumumab are two distinct monoclonal antibodies (mAbs) targeting the epidermal growth factor receptor (EGFR), and both are widely used in combination with chemotherapy or as monotherapy to treat patients with RAS wild-type metastatic colorectal cancer. Although often considered inte...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2019-09-01
|
| Col·lecció: | Frontiers in Oncology |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/article/10.3389/fonc.2019.00849/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|